XTL Biopharmaceuticals Ltd. announced a stock split that will take effect Feb. 10.
XTL Biopharmaceuticals' depositary share will represent 100 ordinary shares of the company at that date as opposed to 20 ordinary shares previously.
The split will help the company regain compliance with Nasdaq's listing requirements.